118 related articles for article (PubMed ID: 29181159)
1. Investigation of the association between the
Tas A; Atabey M; Caglayan G; Bostanci ME; Sahin Bolukbasi S; Topcu O; Silig Y
Biomed Rep; 2017 Nov; 7(5):469-473. PubMed ID: 29181159
[TBL] [Abstract][Full Text] [Related]
2. Significant Association of the MDM2 T309G Polymorphism with Breast Cancer Risk in a Turkish Population.
Yilmaz M; Tas A; Donmez G; Kacan T; Silig Y
Asian Pac J Cancer Prev; 2018 Apr; 19(4):1059-1062. PubMed ID: 29699057
[TBL] [Abstract][Full Text] [Related]
3. Significant association between MDM2 T309G polymorphism and colorectal cancer.
Atabey M; Tas A; Sari I; Bostanci ME; Topcu O; Silig Y
J BUON; 2019; 24(3):1137-1142. PubMed ID: 31424672
[TBL] [Abstract][Full Text] [Related]
4. [Association of murine double minute 2 and P53 polymorphisms with breast cancer susceptibility].
Wang ML; Xu YX; Qian J; Wang FH
Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Feb; 47(2):124-8. PubMed ID: 23719102
[TBL] [Abstract][Full Text] [Related]
5. No association of MDM2 T309G polymorphism with susceptibility to Korean gastric cancer patients.
Cho YG; Choi BJ; Song JH; Kim CJ; Cao Z; Nam SW; Lee JY; Park WS
Neoplasma; 2008; 55(3):256-60. PubMed ID: 18348658
[TBL] [Abstract][Full Text] [Related]
6. Association between murine double minute 2 T309G polymorphism and risk of liver cancer.
Tang T; Song X; Yang Z; Huang L; Wang W; Tan H
Tumour Biol; 2014 Nov; 35(11):11353-7. PubMed ID: 25119589
[TBL] [Abstract][Full Text] [Related]
7. The T309G MDM2 gene polymorphism is a novel risk factor for proliferative vitreoretinopathy.
Pastor-Idoate S; Rodríguez-Hernández I; Rojas J; Fernández I; García-Gutiérrez MT; Ruiz-Moreno JM; Rocha-Sousa A; Ramkissoon Y; Harsum S; MacLaren RE; Charteris D; VanMeurs JC; González-Sarmiento R; Pastor JC;
PLoS One; 2013; 8(12):e82283. PubMed ID: 24349246
[TBL] [Abstract][Full Text] [Related]
8. Association of
Sivonova MK; Jurecekova J; Kaplan P; Hives M; Grendar M; Tomascova A; Dusenka R; Drobkova H; Evin D; Kliment J
Anticancer Res; 2020 Nov; 40(11):6257-6264. PubMed ID: 33109563
[TBL] [Abstract][Full Text] [Related]
9. The T309G murine double minute 2 gene polymorphism is an independent prognostic factor for patients with renal cell carcinoma.
de Martino M; Taus C; Wessely IS; Lucca I; Hofbauer SL; Haitel A; Shariat SF; Klatte T
DNA Cell Biol; 2015 Feb; 34(2):107-12. PubMed ID: 25415135
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis of the MDM2 T309G polymorphism and gastric cancer risk.
Song B; Duan ZY; Zhong YH; Lei N; Yang YQ; Luo KY
Asian Pac J Cancer Prev; 2014 Jan; 14(11):6649-51. PubMed ID: 24377582
[TBL] [Abstract][Full Text] [Related]
11. Role of MDM2 T309G polymorphism in susceptibility and prognosis of nonsmall cell lung cancer: a meta-analysis.
Kong Q; Li P; Tian Q; Ha MW
Genet Test Mol Biomarkers; 2014 May; 18(5):357-65. PubMed ID: 24673452
[TBL] [Abstract][Full Text] [Related]
12. Age-dependent association of MDM2 promoter polymorphisms and uterine leiomyoma in South-East Iran: A preliminary report.
Salimi S; Hajizadeh A; Khodamian M; Pejman A; Fazeli K; Yaghmaei M
J Obstet Gynaecol Res; 2015 May; 41(5):729-34. PubMed ID: 25511444
[TBL] [Abstract][Full Text] [Related]
13. MDM2 promoter polymorphism is associated with increased susceptibility to hepatocellular carcinoma in Turkish population.
Akkiz H; Sümbül AT; Bayram S; Bekar A; Akgöllü E
Cancer Epidemiol; 2010 Aug; 34(4):448-52. PubMed ID: 20447891
[TBL] [Abstract][Full Text] [Related]
14. Relationship Between Murine Double Minute 2 (MDM2) T309G Polymorphism and Endometrial Cancer Risk: A Meta-Analysis.
Xue Z; Zhu X; Teng Y
Med Sci Monit; 2016 Sep; 22():3186-90. PubMed ID: 27604213
[TBL] [Abstract][Full Text] [Related]
15. Association of MDM2 and p53 polymorphisms with the advancement of cervical carcinoma.
Singhal P; Hussain S; Thakur N; Batra S; Salhan S; Bhambani S; Bharadwaj M
DNA Cell Biol; 2013 Jan; 32(1):19-27. PubMed ID: 23210739
[TBL] [Abstract][Full Text] [Related]
16. The ID genotype of MDM2 40 bp insertion/deletion polymorphism was associated with lower risk of SLE.
Salimi S; Rezaei M; Mohammadpour-Gharehbagh A; Sajadian M; Sandoughi M
Postgrad Med J; 2017 Dec; 93(1106):758-761. PubMed ID: 28676527
[TBL] [Abstract][Full Text] [Related]
17. The p53 G72C and MDM2 T309G single nucleotide polymorphisms in patients with Wegener's granulomatosis.
Assmann G; Wieczorek S; Wibisono D; Roemer K; Arning L; Voswinkel J
Clin Exp Rheumatol; 2008; 26(3 Suppl 49):S72-5. PubMed ID: 18799058
[TBL] [Abstract][Full Text] [Related]
18. The association of polymorphic markers Arg399Gln of XRCC1 gene, Arg72Pro of TP53 gene and T309G of MDM2 gene with breast cancer in Kyrgyz females.
Isakova J; Talaibekova E; Aldasheva N; Vinnikov D; Aldashev A
BMC Cancer; 2017 Nov; 17(1):758. PubMed ID: 29132330
[TBL] [Abstract][Full Text] [Related]
19. Murine double minute clone 2,309T/G and 285G/C promoter single nucleotide polymorphism as a risk factor for breast cancer: a Polish experience.
Piotrowski P; Lianeri M; Rubis B; Knuła H; Rybczyńska M; Grodecka-Gazdecka S; Jagodziński PP
Int J Biol Markers; 2012 Jul; 27(2):e105-10. PubMed ID: 22467100
[TBL] [Abstract][Full Text] [Related]
20. MDM2 SNP309 variation contributes to leukemia risk: meta-analyses based on 7259 subjects.
Zhuo W; Zhang L; Ling J; Zhu B; Chen Z
Leuk Lymphoma; 2012 Nov; 53(11):2245-52. PubMed ID: 22563815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
